Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
  •  
Login | Create an Account

26th Psychiatric Pharmacotherapy Update 2014 • Pharmacist (CPE)


Banner

Home About Agenda Speakers   Location CE Credits Supporters

Psychiatric Pharmacotherapy Update Registration

The University of Texas College of Pharmacy welcomes you to the 2014 Psychiatric Pharmacotherapy Update CE event, taking place at the DoubleTree by Hilton in Austin, Texas on October 23-24. The Psychiatric Pharmacotherapy Update traditionally provides 15 hours of CEU's on current treads in mental illness treatment for pharmacists, physicians, psychiatrists, psychologists, advance practice nurses, counselors, and social workers.

Hotel Reservations:  See Location website for more information:  http://www.utexas.edu/pharmacy/ce/conferences/psych/location.html

Date: Oct 23, 2014 07:00 AM - Oct 24, 2014 05:30 PM

Fee

$425.00

CE Hours

15.00

CE Units

1.500

Registration closes on Oct 27, 2014 11:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

“This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit.  The official record of credit may be located in the learner’s e-profile in CPE Monitor®.”
Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

ACPE Logo

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This two-day activity is approved for 1.5 CEUs (15 contact hours) of continuing education credit.  In order to receive 15 contact hours of CE credit, the participant must attend/participate in all sessions of the program, return their completed Record of Attendance Form at the conclusion of the program, and return to this website to complete the online evaluation.
 
MUST COMPLETE CPE EVALUATIONS BY DECEMBER 22, 2014, OR FORFIT CPE CREDIT
As of May 1, 2014, ACPE has placed a strict limit of 60 days to complete the CPE requirements for credit for all pharmacy continuing education programs.  Pharmacists who fail to complete the requirements for credit for this program will forfit CPE credit for this activity.  Per rule set by ACPE, The University of Texas at Austin College of Pharmacy will not be able to process credit after the 60 day deadline, and will not be able to route credits to the NABP eProfiles. 

 

 

Registration closes on Oct 27, 2014 at 11:00 PM

Registration Closed  

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
  • List key trends in new drug development.

Speaker(s)/Author(s)

Stephen R. Saklad, PharmD, BCPP picture

Stephen R. Saklad, PharmD, BCPP, Pharm.D., BCPP
Clinical Associate Professor, UT Austin College of Pharmacy / Director, Psychiatric Pharmacy Program, UT Health Science Center San Antonio , UT Austin College of Pharmacy

Activity Number

0067-0000-14-040-L01-P
Date: 10/23/14
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe current trends for treatment of non-combative PTSD.
  • Examine the differences between combative and non-combative treatment regiments for PTSD.

Speaker(s)/Author(s)

Alan Peterson, PHARM.D., PHD, ABPP
PROFESSOR, UT HEALTH SCIENCE CENTER

Activity Number

0067-0000-14-041-L01-P
Date: 10/23/14
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe potential functional gains demonstrated by atypical antipsychotics.
  • Cite evidence supporting the cognitive benefits of antipsychotics.
  • Describe data summarizing current trends in treatment for schizophrenia.
  • Describe current data in relation to the use of clozapine.
  • Explain alternative treatments of schizophrenia.
  • Describe cognitive therapy approaches in relation to pharmacotherapy treatments.

Speaker(s)/Author(s)

Karen Rascati, Ph.D.
Professor of Health Outcomes, The University of Texas at Austin, University of Texas at Austin

Troy Moore PharmD, MS Pharm, BCPP picture

Troy Moore PharmD, MS Pharm, BCPP
Clinical Pharmacy Specialist – Psychiatry Director, ASHP-Accredited PGY-2 Psychiatric Pharmacy Residency Program Co-Director, Interprofessional Advanced Fellowship in Addiction Treatment, South Texas Veterans Health Care System

Activity Number

0067-0000-14-042-L01-P
Date: 10/23/14
Time: 10:15 AM - 12:15 PM

CE Hours

2.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the effect of genetics on psychotropic disposition and response.
  • Identify cultural factors that influence medication use.
  • Discuss the scope of cultural and diversity competency.

Speaker(s)/Author(s)

Y.W. Francis Lam, Pharm.D., FCCP
Professor of Pharmacology, UT HEALTH SCIENCE CENTER

Activity Number

0067-0000-14-043-L01-P
Date: 10/23/14
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe data/trends in surge of autism diagnosis in TX/US.
  • Discuss pharmacotherapy treatments
  • Discuss the scope of cultural and diversity competency.

Speaker(s)/Author(s)

Dilip J Karnik, M.D.
Medical Director and Founder: Pediatric Neurology, Dell Children's Hospital


Brief Bio : Dr. Karnik site at Dell Children's Hospital http://www.speciallyforchildren.com/specialties/neurology/index.asp

Activity Number

0067-0000-14-044-L01-P
Date: 10/23/14
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Speaker(s)/Author(s)

M. Lynn Crismon picture

M. Lynn Crismon, Pharm.D., FCCP, BCCP
James T. Doluisio Regents Chair & Dean, University of Texas at Austin College of Pharmacy

Activity Number

0067-0000-14-045-L01-P
Date: 10/23/14
Time: 03:15 PM - 04:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Activity Number

0067-0000-14-046-L01-P
Date: 10/23/14
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
Registration Closed  

Registration closes on Oct 27, 2014 at 11:00 PM

Registration Closed  

Activity Number

0067-0000-14-047-L01-P
Date: 10/24/14
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Activity Number

0067-0000-14-048-L01-P
Date: 10/24/14 09:00 AM - 10/02/14 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the trends of patients moving from prescription drug muses to illegal substance / heroin use.
  • Discuss treatment options for heroin addiction.
  • Discuss ethical dilemmas practitioners face when a patient stops use of prescription pills for illegal substances

Speaker(s)/Author(s)

Jane Maxwell, Ph.D.
Sr. Research Scientist, University of Texas at Austin

Activity Number

0067-0000-14-049-L01-P
Date: 10/24/14
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe trends resulting in additions to prescription drugs. Discuss methods to avoid addiction. Discuss treatment methods to end addiction.

Speaker(s)/Author(s)

Thomas Kosten

Activity Number

0067-0000-14-050-L01-P
Date: 10/24/14
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Speaker(s)/Author(s)

Dr. Igor Grant

Jane Maxwell, Ph.D.
Sr. Research Scientist, University of Texas at Austin

Thomas Kosten

Activity Number

0067-0000-14-051-L01-P
Date: 10/24/14
Time: 12:30 PM - 01:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe a patient-centered, team approach to mental health care in primary care.
  • Design an evidence-based medication regimen that fits the individual patient's needs.
  • Evaluate the medication regimen to ensure that it is appropriate, effective, safe, and conveninet.

Speaker(s)/Author(s)

Carla Cobb, Pharm.D., BCPP
University of Montanta

Activity Number

0067-0000-14-052-L01-P
Date: 10/24/14
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe recent changes and trends in the treatment of dementia
  • Describe side effects, Black Box Warnings, and other risks associated with antipsychotic therapy.
  • Discuss alternatives to antipsychotic therapy.
  • Antidepressants in bipolar depression or Ketamine in Depression

Speaker(s)/Author(s)

Rajesh Tampi, MD, MS, DFAPA picture

Rajesh Tampi, MD, MS, DFAPA, MD, MS, FAPA
Professor of Psychiatry, Case Western Reserve University School of Medicine

Activity Number

0067-0000-14-053-L01-P
Date: 10/24/14
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Date: 10/24/14
Time: 03:30 PM - 03:45 PM
Registration Closed  



System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
  • Operating System: Windows 7 or higher, macOS Sierra (10.12) or higher
  • Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Internet Explorer 11, Microsoft Edge, Safari 9 or higher
  • Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
  • Peripherals: Computer speakers or headphones Media Viewing Requirements: Adobe Reader, HTML5
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice.Activities produced by UT Continuing Pharmacy Education are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Texas at Austin College of Pharmacy.
 
The University of Texas at Austin College of Pharmacy • Continuing Pharmacy Education
2409 University Ave., Stop A1904 | Austin, Texas 78712
Comments to:  UTpharmacyCE@austin.utexas.edu
College of Pharmacy, The University of Texas at Austin
 
LMS Powered By: Learning ExpressCE
Copyright © 2024 University of Texas at Austin College of Pharmacy. All Rights Reserved.
About Us Privacy Policy Terms of Service